Marc De Brabander

493 total citations
11 papers, 398 citations indexed

About

Marc De Brabander is a scholar working on Cell Biology, Infectious Diseases and Virology. According to data from OpenAlex, Marc De Brabander has authored 11 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cell Biology, 3 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Marc De Brabander's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). Marc De Brabander is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). Marc De Brabander collaborates with scholars based in Belgium and Germany. Marc De Brabander's co-authors include Paul Lewi, Wolfgang Schäper, Μ. Borgers, H. Van den Bossche, Marcel Joniau, G. Geuens, Jan De Mey, Fred De Clerck, Hugo Neels and Vera Van de Velde and has published in prestigious journals such as Blood, Circulation Research and The American Journal of Medicine.

In The Last Decade

Marc De Brabander

11 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc De Brabander Belgium 6 181 76 75 57 56 11 398
Jean‐Louis Gendrault France 13 102 0.6× 35 0.5× 40 0.5× 26 0.5× 111 2.0× 20 494
L. Svendsen Germany 13 199 1.1× 15 0.2× 38 0.5× 65 1.1× 65 1.2× 22 697
Charles Allen United States 13 92 0.5× 74 1.0× 21 0.3× 14 0.2× 29 0.5× 20 360
Ritsuko Tanaka Japan 10 197 1.1× 28 0.4× 18 0.2× 107 1.9× 31 0.6× 27 435
J. Kenneth Herd United States 10 76 0.4× 27 0.4× 52 0.7× 33 0.6× 10 0.2× 21 344
V. Hornsey United Kingdom 16 385 2.1× 20 0.3× 19 0.3× 37 0.6× 61 1.1× 31 903
G Cartouzou France 16 300 1.7× 67 0.9× 47 0.6× 12 0.2× 33 0.6× 43 723
J. Andrew Bristol United States 16 295 1.6× 130 1.7× 32 0.4× 8 0.1× 26 0.5× 20 626
Leonore A. Herzenberg United States 6 187 1.0× 28 0.4× 22 0.3× 7 0.1× 24 0.4× 7 514
Geneviève Doyon United States 11 196 1.1× 125 1.6× 17 0.2× 13 0.2× 83 1.5× 18 527

Countries citing papers authored by Marc De Brabander

Since Specialization
Citations

This map shows the geographic impact of Marc De Brabander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc De Brabander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc De Brabander more than expected).

Fields of papers citing papers by Marc De Brabander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc De Brabander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc De Brabander. The network helps show where Marc De Brabander may publish in the future.

Co-authorship network of co-authors of Marc De Brabander

This figure shows the co-authorship network connecting the top 25 collaborators of Marc De Brabander. A scholar is included among the top collaborators of Marc De Brabander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc De Brabander. Marc De Brabander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Staszewski, Schlomo, Veronica Miller, Robert Colebunders, et al.. (1996). Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Antiviral Therapy. 1(1). 43–51. 5 indexed citations
3.
Miller, Veronica, Thomas Stark, J. De Crée, et al.. (1996). Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients. AIDS. 10(5). F1–F7. 72 indexed citations
4.
Ginckel, R. Van, et al.. (1992). Levamisole plus 5-fluorouracil inhibits the growth of human colorectal xenografts in nude mice. European Journal of Cancer. 28(6-7). 1137–1139. 5 indexed citations
5.
Wever, Bart De, Raoul Rooman, & Marc De Brabander. (1990). Serum and serotonin induce retraction of calf aortic smooth muscle (CASM) cells in vitro: Inhibition by ketanserin, a 5-HT2 receptor antagonist. Experimental Cell Research. 186(1). 109–114. 3 indexed citations
6.
Ginckel, R. Van, Rudy Willebrords, Marc De Brabander, et al.. (1989). Interaction between the microtubule inhibitor tubulozole and gamma-irradiation in murine tumors in vivo. International Journal of Radiation Oncology*Biology*Physics. 16(1). 177–182. 2 indexed citations
7.
Nuydens, Rony, Hugo Geerts, Marc De Brabander, & Marc Moeremans. (1988). Dynamics Of Cell Components Investigated With Nanovid Microscopy. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 909. 241–241. 1 indexed citations
8.
Borgers, Μ., H. Van den Bossche, & Marc De Brabander. (1983). The mechanism of action of the new antimycotic ketoconazole. The American Journal of Medicine. 74(1). 2–8. 67 indexed citations
9.
Clerck, Fred De, Marc De Brabander, Hugo Neels, & Vera Van de Velde. (1981). Direct evidence for the contractile capacity of endothelial cells. Thrombosis Research. 23(6). 505–520. 34 indexed citations
10.
Brabander, Marc De, G. Geuens, Jan De Mey, & Marcel Joniau. (1981). Nucleated assembly of mitotic microtubules in living PTK2 cells after release from nocodazole treatment. Cell Motility. 1(4). 469–483. 64 indexed citations
11.
Schäper, Wolfgang, Marc De Brabander, & Paul Lewi. (1971). DNA Synthesis and Mitoses in Coronary Collateral Vessels of the Dog. Circulation Research. 28(6). 671–679. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026